Animal models for FXTAS

The Fragile X-Associated Tremor Ataxia Syndrome (FXTAS)

Volumn , Issue , 2010, Pages 123-136

  Willemsen, Rob ^a   Li, Yujing ^b   Berman, Robert F ^c   Brouwer, Judith R ^a   Oostra, Ben A ^a   Jin, Peng ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84919847156     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4419-5805-1_8     Document Type: Chapter

References (53)

1. Allen, E. G. et al. 2004. A study of the distributional characteristics of FMR1 transcript levels in 238 individuals. Hum Genet 114:439-447.
2. Bacalman, S. et al. 2006. Psychiatric phenotype of the fragile X-associated tremor/ataxia syndrome (FXTAS) in males: newly described fronto-subcortical dementia. J Clin Psychiatry 67:87.94.
3. Bergink, S. et al. 2006. The DNA repair-ubiquitin-associated HR23 proteins are constituents of neuronal inclusions in specific neurodegenerative disorders without hampering DNA repair. Neurobiol Dis 23:708.716.
4. Bilen, J., Bonini, N. M. 2005. Drosophila as a model for human neurodegenerative disease. Annu Rev Genet 39:153.171.
5. Bontekoe, C. J. M. et al. 1997. FMR1 premutation allele is stable in mice. Eur J Hum Genet 5:293.298.
6. Bontekoe, C. J. et al. 2001. Instability of a (CGG) (98) repeat in the Fmr1 promoter. Hum Mol Genet 10:1693.1699.
7. Bourgeois, J. A. et al. 2007. Cognitive, anxiety and mood disorders in the fragile X-associated tremor/ataxia syndrome. Gen Hosp Psychiatry 29:349.356.
8. Brouwer, J. R. et al. 2007. Elevated Fmr1 mRNA levels and reduced protein expression in a mouse model with an unmethylated fragile X full mutation. Exp Cell Res 313:244.253.
9. Brouwer, J. R. et al. 2008a. Altered hypothalamus-pituitary-adrenal gland axis regulation in the expanded CGG-repeat mouse model for fragile X-associated tremor/ataxia syndrome. Psychoneuroendocrinology 33:863.873.
10. Brouwer, J. R. et al. 2008b. CGG-repeat length and neuropathological and molecular correlates in a mouse model for fragile X-associated tremor/ataxia syndrome. J Neurochem 107:1671.1682.
11. Chan, H. Y. et al. 2002. Genetic modulation of polyglutamine toxicity by protein conjugation pathways in drosophila. Hum Mol Genet 11:2895.2904.
12. Chen, Y., Tassone, F., Berman, R. F., Hagerman, P. J., Hagerman, R. J., Willemsen, R., Pessah, I. N. 2010 Jan 1. Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet 19(1):196.208.
13. Cornish, K. M. et al. 2008. Age-dependent cognitive changes in carriers of the fragile X syndrome. Cortex 44:628.636.
14. Cummings, C. J. et al. 2001. Over-expression of inducible Hsp70 chaperone suppresses neuropathology and improves motor function in SCA1 mice. Hum Mol Genet 10:1511.1518.
15. De Fougerolles, A. et al. 2007. Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 6:443.453.
16. Entezam, A. et al. 2007. Regional FMRP deficits and large repeat expansions into the full mutation range in a new fragile X premutation mouse model. Gene 395:125.134.
17. Entezam, A., Usdin, K. 2007. ATR protects the genome against CGG. CGG-repeat expansion in fragile X premutation mice. Nucleic Acids Res 36:1050.1056.
18. Fernandez-Funez, P. et al. 2000. Identification of genes that modify ataxin-1-induced neurodegeneration. Nature 408:101.106.
19. Greco, C. M. et al. 2002. Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers. Brain 125:1760.1771.
20. Greco, C. M. et al. 2006. Neuropathology of fragile X-associated tremor/ataxia syndrome (FXTAS). Brain 129:243.255.
21. Greco, C. M. et al. 2007. Testicular and pituitary inclusion formation in fragile X associated tremor/ataxia syndrome. J Urol 177:1434.1437.
22. Grigsby, J. et al. 2008. Cognitive profile of fragile X premutation carriers with and without fragile X-associated tremor/ataxia syndrome. Neuropsychology 22:48.60.
23. Hagerman, R. J. et al. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57:127.130.
24. Hagerman, P. J., Hagerman, R. J. 2004. Fragile X-associated tremor/ataxia syndrome (FXTAS). Ment Retard Dev Disabil Res Rev 10:25.30.
25. Handa, V. et al. 2003. The fragile X syndrome repeats form RNA hairpins that do not activate the interferon-inducible protein kinase, PKR, but are cut by dicer. Nucleic Acids Res 31:6243.6248.
26. Hessl, D. et al. 2005. Abnormal elevation of FMR1 mRNA is associated with psychological symptoms in individuals with the fragile X premutation. Am J Med Genet B Neuropsychiatr Genet 139B:115-121.
27. Hessl, D. et al. 2006. Amygdala dysfunction in men with the fragile X premutation. Brain 130(2):404-416.
28. Hunter, J. E. et al. 2008. Investigation of phenotypes associated with mood and anxiety among male and female fragile X premutation carriers. Behav Genet 38(5):493-502.
29. Iwahashi, C. et al. 2006. Protein composition of the intranuclear inclusions of FXTAS. Brain 129:256-271.
30. Iyer, R. R. et al. 2000. DNA polymerase III proofreading mutants enhance the expansion and deletion of triplet repeat sequences in Escherichia coli. J Biol Chem 275:2174-2184.
31. Jacquemont, S. et al. 2004. Aging in individuals with the FMR1 mutation. Am J Ment Retard 109:154-164.
32. Jakupciak, J. P., Wells, R. D. 1999. Genetic instabilities in (CTG. CAG) repeats occur by recombination. J Biol Chem 274:23468-23479.
33. Jin, P. et al. 2003. RNA-mediated neurodegeneration caused by the fragile X premutation rCGG repeats in drosophila. Neuron 39:739-747.
34. Jin, P. et al. 2007. Pur alpha binds to rCGG repeats and modulates repeat-mediated neurodegeneration in a drosophila model of fragile X tremor/ataxia syndrome. Neuron 55:556-564.
35. Jin, P., Warren, S. T. 2003. New insights into fragile X syndrome: from molecules to neurobehaviors. Trends Biochem Sci 28:152-158.
36. Kazemi-Esfarjani, P., Benzer, S. 2000. Genetic suppression of polyglutamine toxicity in drosophila. Science 287:1837-1840.
37. Kenneson, A. et al. 2001. Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum Mol Genet 10:1449-1454.
38. Khalili, K. et al. 2003. Pur alpha is essential for postnatal brain development and developmentally coupled cellular proliferation as revealed by genetic inactivation in the mouse. Mol Cell Biol 23:6857-6875.
39. Krol, J. et al. 2007. Ribonuclease dicer cleaves triplet repeat hairpins into shorter repeats that silence specific targets. Mol Cell 25:575-586.
40. Ladd, P. D. et al. 2007. An antisense transcript spanning the CGG repeat region of FMR1 is upregulated in premutation carriers but silenced in full mutation individuals. Hum Mol Genet 16:3174-3187.
41. Lavedan, C. N. et al. 1997. Trinucleotide repeats (CGG) 22TGG (CGG) 43TGG (CGG) 21 from the fragile X gene remain stable in transgenic mice. Hum Genet 100:407-414.
42. Lavedan, C. et al. 1998. Long uninterrupted CGG repeats within the first exon of the human FMR1 gene are not intrinsically unstable in transgenic mice. Genomics 50:229-240.
43. Louis, E. et al. 2006. Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: a clinical-pathological study. Mov Disord 27:193-201.
44. Peier, A., Nelson, D. 2002. Instability of a premutation-sized CGG repeat in FMR1 YAC transgenic mice. Genomics 80:423-432.
45. Primerano, B. et al. 2002. Reduced FMR1 mRNA translation efficiency in fragile X patients with premutations. RNA 8:1-7.
46. Sofola, O. A. et al. 2007a. Argonaute-2 dependent rescue of a drosophila model of FXTAS by FRAXE premutation repeat. Hum Mol Genet 16:2326-2332.
47. Sofola, O. A. et al. 2007b. RNA-binding proteins hnRNP A2/B1 and CUGBP1 suppress fragile X CGG premutation repeat-induced neurodegeneration in a drosophila model of FXTAS. Neuron 55:565-571.
48. Tassone, F. et al. 2000. Elevated levels of FMR1 mRNA in carrier males: A new mechanism of involvement in the Fragile-X syndrome. Am J Hum Genet 66:6-15.
49. Tassone, F. et al. 2004. Intranuclear inclusions in neural cells with premutation alleles in fragile X associated tremor/ataxia syndrome. J Med Genet 41:E43.
50. Van Dam, D. et al. 2005. Cognitive decline, neuromotor and behavioural disturbances in a mouse model for Fragile-X-associated tremor/ataxia syndrome (FXTAS). Behav Brain Res 162:233-239.
51. Warrick, J. M. et al. 1998. Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in drosophila. Cell 93:939-949.
52. White, P. J. et al. 1999. Stability of the human fragile X (CGG) (n) triplet repeat array in saccharomyces cerevisiae deficient in aspects of DNA metabolism. Mol Cell Biol 19:5675-5684.
53. Willemsen, R. et al. 2003. The FMR1 CGG repeat mouse displays ubiquitin-positive intranuclear neuronal inclusions; implications for the cerebellar tremor/ataxia syndrome. Hum Mol Genet 12:949-959.